Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXDX | AMGN | BMY | VRTX | GILD |
| Company | Prometheus Biosciences Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 199.68 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 199.98 | 290.57 | 58.46 | 455.43 | 89.94 |
| Low | 199.60 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 199.92 | 290.36 | 58.45 | 449.28 | 89.68 |
| Change | +0.18 | +2.49 | +0.57 | -1.95 | +1.05 |
| % Change | +0.09% | +0.86% | +0.98% | -0.43% | +1.18% |
| Volume | 1,860,600 | 1,573,208 | 3,908,838 | 736,666 | 1,902,071 |
| 20-Day Average Volume | 1,174,595 | 2,821,750 | 12,207,539 | 1,305,247 | 7,414,943 |
| Previous Close | 199.74 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 198.02 | 307.42 | 55.92 | 479.24 | 90.89 |
| 20-Day Raw Stochastic | 99.23% | 27.46% | 69.09% | 7.05% | 28.04% |
| 20-Day Relative Strength | 81.45% | 36.61% | 60.68% | 40.89% | 53.40% |
| Weighted Alpha | +110.70 | +1.98 | +26.01 | +18.07 | +25.90 |
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 88% Buy | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.47% since 06/08/23 | -1.99% since 11/14/24 | -0.49% since 11/14/24 | -6.93% since 11/14/24 | -2.64% since 11/14/24 |
| Low | 198.91 on 06/09/23 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 199.98 on 06/15/23 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | +2.82% since 05/15/23 | -8.43% since 10/21/24 | +11.69% since 10/21/24 | -5.79% since 10/21/24 | +3.92% since 10/21/24 |
| Low | 189.76 on 05/16/23 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 199.98 on 06/15/23 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +72.97% since 03/15/23 | -11.89% since 08/21/24 | +20.18% since 08/21/24 | -7.35% since 08/21/24 | +19.36% since 08/21/24 |
| Low | 104.55 on 03/30/23 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 199.98 on 06/15/23 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +85.68% since 12/15/22 | -7.88% since 05/21/24 | +37.72% since 05/21/24 | +1.90% since 05/21/24 | +33.27% since 05/21/24 |
| Low | 103.33 on 01/06/23 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 199.98 on 06/15/23 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,558,772 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 47,813 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 6,810,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -141,750,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 1,110,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -40,880,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | -0.49 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.86 on 05/09/23 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 08/10/23 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |